Skip to main content
Behavioral Healthcare Executive
Abuse, PTSD & Trauma
Alzheimer’s Disease, Dementia & Cognitive Disorders
Child & Adolescent Psychiatry
Major Depressive Disorder
Psych Congress Year-Round
Schizophrenia & Psychotic Disorders
Your Questions Answered
Cocaine, Meth & Stimulant Summit
Elevate by Psych Congress
Evolution of Psychotherapy
Lunch and Learn Series
National Conference on Addiction Disorders East
National Conference on Addiction Disorders West
Psych Congress Regionals
Rx Drug Abuse & Heroin Summit
Treatment Center Investment & Valuation Retreat
Insights from the APA Annual Meeting
Psych Congress On-Demand
NCAD East On-Demand
Centers of Excellence
Advertising And Event Opportunities
Editorial Advisory Board
Report Quantifies Staggering Impact of Overdose on Hospital Care
January 07, 2019
An analysis from Premier Inc. found that nearly 650 hospitals saw $1.94 billion in costs related to care for patients experiencing an opioid overdose.
Is transformative investment on the horizon for behavioral healthcare?
December 17, 2018
Here are five key realities to understand and accept in regards to the behavioral healthcare infrastructure.
Kaleo CEO defends Evzio $4,000 price tag on ‚Äô60 Minutes‚Äô
November 19, 2018
Kaleo CEO Spencer Williamson told CBS’s “60 Minutes” his company would drop the price of the Evzio naloxone auto-injector if insurers and pharmacy benefit managers stop blocking…
NCAD: Payer audits, crisis communications highlight executive sessions
August 21, 2018
Presenters weigh in on the importance of controlling your organizational narrative in times of crisis, how to avoid payer audits, technology considerations and sober home standards.
7 tips for better payer contracts
July 09, 2018
As payer networks shrink, data is a key contract negotiating tool.
ASAM designs MAT payment model
April 24, 2018
The Patient-Centered Opioid Addiction Treatment alternative payment model would desegregate payments for medical, psychological and social support services for OUD treatment.
7 predictions for an unpredictable new year
December 21, 2017
Politically, economically and legislatively, 2017 was a tumultuous year. Our predictions for the 2018 healthcare market and some practical recommendations for action are described below.
Medicare places few restrictions on opioid prescribing
October 16, 2017
A study released by researchers at Yale University shows one-third of opioid medications were prescribed with no limitations from Medicare plans.
The opioid emergency declaration is not dead
September 18, 2017
New Jersey Gov. Chris Christie said that the notorious state of emergency declaration is still in play, but remember that practical developments are on hold until federal officials complete the…
FACT FILE: OIG flags opioid misuse, questionable prescribing in Medicare Part D
August 10, 2017
A study of Medicare Part D data from 2016 by the U.S. Department of Health and Human Services Office of Inspector General identifies cases of extreme use of opioids, questionable prescribing and…
Back to Top